|
Evaluation and Treatment of Patients with Dermatologic Diseases Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Evaluation and Treatment of Patients with Dermatologic Diseases conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Evaluation and Treatment of Patients with Dermatologic Diseases Clinical research trials and Evaluation and Treatment of Patients with Dermatologic Diseases healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Evaluation and Treatment of Patients with Dermatologic Diseases. Evaluation and Treatment of Patients with Dermatologic Diseases Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Evaluation and Treatment of Patients with Dermatologic Diseases clinical trial. Subjects frequently obtain the most expert healthcare possible for their Evaluation and Treatment of Patients with Dermatologic Diseases condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation and Treatment of Patients with Dermatologic Diseases  Evaluation and Treatment of Patients with Dermatologic Diseases
Evaluation and Treatment of Patients with Dermatologic Diseases
For Condition: Connective Tissue Disease,Skin Disease
Status: Recruiting
Sponsor(s): National Cancer Institute (NCI) ,
Synopsis: This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.
Details: This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.
Eligibility:
Study Type: Interventional, Training
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Patients of any age, of both genders, and all racial/ethnic groups with dermatologic diseases or systemic diseases with cutaneous manifestations. Women of childbearing potential, or who are pregnant or lactating, will undergo tests and procedures, and/or receive medications for which data exists proving minimal risk to the fetus or child. Only tests that are clinically indicated for diagnosis will be performed. Patients must be referred by a physician. EXCLUSION CRITERIA: Patients with cognitive impairment. Pregnancy or lactation, if this status precludes proposed diagnostic procedures or therapies because of known untoward effects on mother and/or child.
Total Enrollment: 400
Location and Contact Information:
National Cancer Institute (NCI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Clinical Support Center/NCI 1-888-624-1937
Additional Information:
Study ID Numbers: 960102; 96-C-0102
Study Start Date: June 10, 1996
Record last reviewed: May 1, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001506
Other Skin Disease Studies:
1. Study of Heritable Connective Tissue Disorders
2. Evaluation and Treatment of Patients with Dermatologic Diseases
Related Studies:
Other Skin Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluation and Treatment of Patients with Dermatologic Diseases
|
|
|
|
|
|
|
|
